Impact of Integrated Care Pathways for Prevention of Post-operative

Status Recruiting

Clinical Trial Summary

A prospective randomized control trial will be conducted at Good Samaritan Hospital and TriHealth Evendale Hospital. Subjects will receive total hip or knee surgery and follow-up via standard care at the discretion of the treating physician or the experimental study arm in which all patients will undergo the integrated care pathway.

Clinical Trial Description

Patients will be randomized to the control group or the experimental group. Patients in the control group will receive the treating physician's standard of care, and undergo bladder scans in the post anesthesia care unit (PACU), upon admission to the unit, and prior to discharge from the hospital. Patients in the experimental group will undergo a multimodal pain control care pathway that minimizes opioid consumption. The primary endpoint will be the presence of or absence of post-operative urinary retention (POUR) between discharge from the PACU and prior to discharge from the hospital. POUR will be defined as bladder volume of greater than 500cc and the inability to void for at least 2 hours within the first 24 hours. POUR, once identified will be treated with intermittent straight catheterization (ISC). Secondary endpoints will include opioid consumption (in morphine milligram equivalents; MME), genito-urinary consultation, type (knee or hip) and duration of surgery, type of anesthesia, duration of anesthesia, total amount of IV fluids, blood loss, length of hospital stay (LOS), discharge status (home with early outpatient physical therapy, etc.), time of first spontaneous voiding, and the number of ISCs and any necessary indwelling catheterization and adverse events of interest including POUR, post-operative nausea and vomiting (PONV), severe pain of 7 or greater on the numeric rating scale(NRS), blood loss requiring transfusion, and lower urinary tract symptoms (LUTS). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03863743
Study type	Interventional
Source	TriHealth Inc.
Contact	Justin Osborne
Phone	513-865-5211
Email	Justin_Osborne@trihealth.com
Status	Recruiting
Phase	N/A
Start date	February 5, 2019
Completion date	February 5, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05666479` - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Recruiting	`NCT05002387` - Diagnostic Knee Needle Arthroscopy in Predicting Unicompartmental Knee Osteoarthritis	N/A
Recruiting	`NCT06080763` - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed	`NCT03008967` - A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark	N/A
Withdrawn	`NCT02255877` - ZIPS Study - Zip Incision Approximation vs. STAPLE	Phase 4
Completed	`NCT02642731` - Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty	N/A
Completed	`NCT02525588` - Polyethylene Wear Study on the Triathlon Total Knee Prosthesis	N/A
Completed	`NCT01799772` - The Feasibility of a Comprehensive Behavioral Intervention in Patient Post TKA	Phase 1/Phase 2
Completed	`NCT02520531` - Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty	N/A
Completed	`NCT03183856` - Comparison of Ambulatory and Functional Improvement by Morning Walk	N/A
Completed	`NCT03569397` - Music Therapy Versus Control for Total Knee Arthroplasty	N/A
Terminated	`NCT02711592` - Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study	N/A
Completed	`NCT03145493` - Effect of Suction Drains in Total Knee Arthroplasty With Tranexamic Acid	N/A
Terminated	`NCT05602701` - Preoperative Prediction of Postoperative Physical Function
Recruiting	`NCT03570944` - Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
Completed	`NCT02773537` - Motor-Sparing Peripheral Nerve Blockade Facilitates Mobility Post Total Knee Arthroplasty: A Randomized Controlled Trial	N/A
Withdrawn	`NCT02553122` - The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty	Phase 3
Recruiting	`NCT02385383` - An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study	N/A
Terminated	`NCT02155712` - Triathlon Tritanium Knee Outcomes Study	N/A
Completed	`NCT02121392` - Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR) — POUR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms